Potential conflict of interest: Nothing to report.
Helicobacter pylori induced cognitive dysfunction might be associated with falls and fractures in cirrhosis†
Article first published online: 4 FEB 2013
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 57, Issue 3, page 1284, March 2013
How to Cite
Kountouras, J., Zavos, C., Deretzi, G., Vardaka, E., Boziki, M., Gavalas, E., Kouklakis, G., Katsinelos, P., Venizelos, I., Nikolaidou, C., Polyzos, S. A. and Giartza-Taxidou, E. (2013), Helicobacter pylori induced cognitive dysfunction might be associated with falls and fractures in cirrhosis. Hepatology, 57: 1284. doi: 10.1002/hep.25926
- Issue published online: 28 FEB 2013
- Article first published online: 4 FEB 2013
- Accepted manuscript online: 28 JUN 2012 12:00AM EST
- Manuscript Accepted: 4 JUN 2012
To the Editor:
In their prospective series, Soriano et al.1 concluded that cognitive dysfunction (CD) is a factor associated with falls in patients with cirrhosis, and further studies are warranted to address the mechanisms implicated in this predisposition and to design preventive strategies.
Apart from CD causes that can be the result of multiple issues, including the etiology of cirrhosis, mentioned by the authors,1 Helicobacter pylori infection (Hp-I) appears to be a common denominator associated with CD-related falls and fractures and liver cirrhosis.2-4 In this respect, we reported that Hp-I is frequently detected in neurodegenerative diseases including CD and Alzheimer's disease (AD) and Hp eradication may positively influence AD manifestations at 2- and 5-year clinical endpoints,2 thereby supporting a role for this common infection in the pathobiology of the disease. Others also found that AD patients infected by Hp tended to be more cognitively impaired, and patients with dementia have a higher risk of falls and fractures3; Hp-I may also be responsible for osteoporosis. Moreover, hepatitis B (HBV) and C (HCV) are among the commonest causes of liver cirrhosis worldwide4, 5 and Hp-I is strongly associated with HBV- and HCV-related cirrhosis in Europe (Italy); Hp-I is more common in cirrhosis patients with hepatic encephalopathy (HE) than in those without,5 and HE is not a fully reversible condition.
Summarizing the aforementioned data, Hp may be involved in the pathophysiology of cirrhosis-related CD by several mechanisms,4 such as the release of proinflammatory and vasoactive substances, involved through blood-brain barrier (BBB) disruption, in a number of vascular disorders including AD, which can lead to long-term neurologic deficits; promoting platelet-leukocyte aggregation proposed to play pathophysiologic roles in AD and liver fibrosis; producing reactive oxygen metabolites involved in the AD pathophysiology and complications of cirrhosis; or influencing the apoptotic process, an important form of cell death in AD and cirrhosis. Finally, activated monocytes (possibly infected with Hp due to defective autophagy resulting in Hp replication in autophagic vesicles) might also enter the brain due to BBB disruption contributing to cirrhosis-related CD development associated with falls and fractures.3
- 1Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. HEPATOLOGY 2012; 55: 1922-1930., , , , , , et al.
- 2Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol 2010; 23: 199-204., , , , , , et al.
- 3Emotional and psychological distress of persons involved in the care of patients with Alzheimer disease predicts falls and fractures in their care recipients. Dement Geriatr Cogn Disord 2010; 30: 33-38., , , , , , et al.
- 4Impact of Helicobacter pylori on chronic hepatitis C-related cognitive dysfunction. J Neuroimmunol 2011; 233: 254-256., , , , , , et al.
- 5Helicobacter pylori might contribute to persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2011; 9: 624., , .
Jannis Kountouras M.D., Ph.D.*, Christos Zavos M.D., Ph.D.*, Georgia Deretzi M.D., Ph.D.*, Elizabeth Vardaka Ph.D.*, Marina Boziki M.D.*, Emmanouel Gavalas M.D.*, George Kouklakis M.D., Ph.D.*, Panagiotis Katsinelos M.D., Ph.D.*, Ioannis Venizelos M.D., Ph.D.*, Christina Nikolaidou M.D.*, Stergios A. Polyzos M.D., Ph.D.*, Evaggelia Giartza-Taxidou M.D., Ph.D.*, * Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece.